clinical trial · NCT06302491
A Study of Safety and Efficiency of AND017 in Patients With β-thalassemia
β -ThalassemiaAND017 capsulesAND017 Placebo
brief summary
This is a phase II, randomized, double-blinded, placebo-controlled study to treat patients with transfusion-dependent and non-transfusion dependent β -thalassemia with AND017 and optimal supportive care, including blood transfusion and iron removal, based on the clinician's judgment and practice.
started
May 27, 2024
primary completion
Dec 1, 2026
completion
Jul 1, 2027
last updated
Feb 27, 2026
official title
A Study of Safety and Efficiency of AND017 in Patients With Transfusion Dependent and Non-transfusion Dependent β-thalassemia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol